ELX-02 disulfate
Code | Size | Price |
---|
TAR-T19306-5mg | 5mg | £724.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T19306-10mg | 10mg | £1,066.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
ELX-02 disulfate is being developed as a therapy for genetic diseases caused by nonsense mutations.ELX-02 disulfate (NB-124 disulfate) is an investigational, advanced synthetic eukaryotic ribosome selective glycoside (ERSG).
CAS:
2244622-33-9
Formula:
C19H42N4O18S2
Molecular Weight:
678.68
Purity:
0.98
SMILES:
OS(O)(=O)=O.OS(O)(=O)=O.[H][C@@]1(O[C@@H](O[C@]2([H])[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@@]2([H])O[C@]([H])([C@@H](C)O)[C@@H](O)[C@H](O)[C@H]2N)[C@H](O)[C@@H]1O)[C@H](C)N
References
1. Leubitz A, et al. Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of ELX-02, a Potential Treatment for Genetic Disorders Caused by Nonsense Mutations, in Healthy Volunteers. Clin Pharmacol Drug Dev. 2019 Jan 16.